News Report · Infectious Disease

CDC Recommends Universal Hepatitis B Vaccination for Adults 19–59

July 22, 2026

Date

Dec 5, 2024

Topic

Universal Hepatitis B vaccination for adults 19–59

Impact

Eligible expands from risk-based groups to all adults aged 19–59

Specialty

Infectious disease and primary care

Clinical Perspective

Workflow Update EHR prompts and standing orders to flag all patients aged 19–59 for HepB vaccination at preventive and acute visits to reduce missed opportunities and simplify offer documentation.

Economics Broadening eligibility may increase vaccine demand and upfront clinic costs but can reduce downstream costs by preventing new chronic HBV cases; check payer coverage and billing codes aligned with the adult schedule.

Outcomes Shifting to age-based vaccination should increase uptake and lower transmission risk in the adult population by removing reliance on risk screening, improving population immunity.

Dr. Natalie Russo · Infectious Disease

What Happened

The Centers for Disease Control and Prevention (CDC) updated its hepatitis B recommendation — referenced here as CDC hepatitis B guidelines 2026 — to recommend universal Hepatitis B vaccination for all adults aged 19–59 years, as published in an MMWR on December 5, 2024 [6]. The change replaces the previous risk-based strategy that focused vaccination on persons with identified risk factors and contact exposures and has been incorporated into the adult immunization schedule and CDC vaccination guidance pages through 2025 updates [7][5]. The update affects primary care, obstetrics, infectious disease, pharmacy and public health vaccination programs across the United States by widening eligibility to include all adults in this age band [6].

Why It Matters

Hepatitis B causes acute and chronic liver disease, and adults remain a reservoir for transmission when susceptible individuals are not vaccinated; moving from risk-based to universal vaccination reduces missed opportunities that arise from incomplete risk assessment in busy clinical settings [6]. The change affects every clinician who delivers adult immunizations because prior guidance required clinicians to identify specific behavioral or medical risks before offering vaccine; many patients without documented risk still remain susceptible. The MMWR and CDC vaccine pages note that prevaccination testing should not be a barrier to vaccinating susceptible adults, which addresses workflow barriers in populations with sporadic access to care [5][6]. The update was prompted by evidence that risk-based programs fail to achieve high coverage and by CDC’s review of hepatitis B epidemiology and vaccine-preventable transmission, and the change was folded into the published adult immunization schedule to guide implementation [6][7].

What Changed

Previous: Hepatitis B vaccination recommended only for adults with specific risk factors such as injection drug use, multiple sexual partners, or household contact with infected persons; After: Universal recommendation for routine vaccination of all adults aged 19–59 years regardless of reported risk [6]. [6]
Previous: Vaccination decision relied on documented risk assessment before offering vaccine; After: Vaccination may be offered without prevaccination serologic testing to avoid missed opportunities, with testing reserved when it will change management [5]. [5]
Previous: Adult immunization schedule listed HepB for specific risk groups and certain clinical indications; After: The adult immunization schedule now reflects universal HepB recommendation for ages 19–59 and continues to list older-adult and risk-based indications separately [7]. [7]
Previous: Series completion and catch-up strategies varied by clinic; After: Clinics should offer the complete HepB vaccine series or accelerated options according to CDC vaccine administration guidance at the time of the first visit to improve completion rates [5]. [5]
Previous: Insurance coverage and ordering focused on risk-identified encounters; After: Routine ordering and standing protocols in primary care and obstetric clinics should be updated to include all 19–59 year olds to align with the schedule and reduce missed vaccination opportunities [7]. [7]
Previous: Communication to patients focused on risk-based protection messages; After: Patient counseling should be simplified to state that HepB vaccination is routinely recommended for nearly all adults 19–59, which may increase acceptance and streamline consent conversations [8]. [8]

What This Means for Your Practice

Primary care clinicians, obstetricians, and clinic vaccination teams in outpatient and community settings will need to change intake workflows so that age, not detailed risk screening, prompts Hepatitis B vaccine offering at routine visits and preventative care encounters; electronic health record prompts and standing orders should be updated to flag all patients aged 19–59 as eligible and to document offers and series initiation. Pharmacy immunizers and public health clinics should align inventory and education materials with broader demand and use CDC vaccine administration guidance to choose scheduling intervals that maximize completion, while occupational health and pre-travel services should adopt the same age-based approach. As you update order sets and patient materials and track series completion rates, how will your practice reliably capture vaccinations given across multiple settings and close gaps in series completion?

Sources and Further Reading

[1] Centers for Disease Control and Prevention. What Vaccines are Recommended for You | Adult Vaccines | CDC. Date not specified. URL: https://www.cdc.gov/vaccines-adults/recommended-vaccines/index.html

[2] Centers for Disease Control and Prevention. Adult Immunization Schedule by Age (Addendum updated July 2 2025). Jul 2 2025. URL: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html

[3] Centers for Disease Control and Prevention. Hepatitis B Vaccine Administration | Hepatitis B | CDC. Sep 18 2025. URL: https://www.cdc.gov/hepatitis-b/hcp/vaccine-administration/index.html

[4] Centers for Disease Control and Prevention. Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19-59 Years - United States, 2024. Dec 5 2024. URL: https://www.cdc.gov/mmwr/volumes/73/wr/mm7348a3.htm

References

Clinical Perspective

Outcomes Shifting to age-based vaccination should increase uptake and lower transmission risk in the adult population by removing reliance on risk screening, improving population immunity.

Dr. Natalie Russo · Infectious Disease

What Happened

Why It Matters

What Changed

Previous: Hepatitis B vaccination recommended only for adults with specific risk factors such as injection drug use, multiple sexual partners, or household contact with infected persons; After: Universal recommendation for routine vaccination of all adults aged 19–59 years regardless of reported risk [6]. [6]

Previous: Vaccination decision relied on documented risk assessment before offering vaccine; After: Vaccination may be offered without prevaccination serologic testing to avoid missed opportunities, with testing reserved when it will change management [5]. [5]

Previous: Adult immunization schedule listed HepB for specific risk groups and certain clinical indications; After: The adult immunization schedule now reflects universal HepB recommendation for ages 19–59 and continues to list older-adult and risk-based indications separately [7]. [7]

Previous: Series completion and catch-up strategies varied by clinic; After: Clinics should offer the complete HepB vaccine series or accelerated options according to CDC vaccine administration guidance at the time of the first visit to improve completion rates [5]. [5]

Previous: Insurance coverage and ordering focused on risk-identified encounters; After: Routine ordering and standing protocols in primary care and obstetric clinics should be updated to include all 19–59 year olds to align with the schedule and reduce missed vaccination opportunities [7]. [7]